BRUSSELS (Sputnik) - The European Commission is negotiating with the US-based Gilead Sciences company, which is producing the Remdesivir antiviral drug used against COVID-19, the possibility of providing the EU with a sufficient number of doses of the drug in light of reports that the US intends to stockpile the doses, the official statement said.
